THE GUT–BRAIN AXIS AND PSYCHOBIOTICS: IMPLICATIONS FOR MENTAL HEALTH – A NARRATIVE REVIEW

Authors

DOI:

https://doi.org/10.31435/ijitss.4(52).2026.6802

Keywords:

Psychobiotics, Gut–brain Axis, Depression, Anxiety, Microbiota, Neuroinflammation

Abstract

Background: The gut–brain axis has emerged as a key regulatory network linking intestinal microbiota with central nervous system activity. Increasing evidence suggests that gut dysbiosis contributes to the pathophysiology of depression and anxiety disorders through mechanisms involving neuroinflammation, hypothalamic–pituitary–adrenal (HPA) axis dysregulation, impaired intestinal barrier integrity, altered tryptophan metabolism, and abnormal microbial metabolite production.

Aim: This review aimed to summarize the current evidence regarding the role of the gut–brain axis and psychobiotics in mental health, with particular emphasis on mechanistic pathways and recent clinical studies.

Material and methods: A narrative review of the literature indexed in PubMed, Scopus, and Web of Science from 2019 to 2026 was conducted. Particular attention was given to randomized controlled trials, meta-analyses, mechanistic studies, and recent reviews on psychobiotics, gut microbiota, depression, anxiety, neuroinflammation, and precision psychiatry.

Results: Current evidence indicates that selected psychobiotic strains, particularly Lactobacillus and Bifidobacterium species, may improve depressive and anxiety symptoms by modulating inflammatory cytokines, microglial activation, vagus nerve signaling, short-chain fatty acid synthesis, and serotonin precursor metabolism. Clinical studies have suggested modest but clinically relevant improvements in mood, cognitive function, stress response, and sleep quality following psychobiotic supplementation. Synbiotic therapy and Mediterranean dietary interventions may further enhance therapeutic outcomes.

Conclusions: The gut–brain axis is a promising target in modern psychiatry. Although psychobiotics may constitute a valuable adjunctive strategy for treating depressive and anxiety disorders, further large-scale standardized clinical studies are necessary to establish strain-specific efficacy, optimal treatment duration, and clinically applicable biomarkers.

References

Skonieczna-Żydecka, K., et al. (2024). Synbiotics in psychiatric disorders: Mechanisms and therapeutic implications. Nutrients, 16(2), 281. https://doi.org/10.3390/nu16020281

Chahwan, B., et al. (2019). Gut feelings: A randomised, triple-blind, placebo-controlled trial of probiotics for depressive symptoms. BMJ Open, 9, e026546. https://doi.org/10.1136/bmjopen-2018-026546

Dean, J., & Keshavan, M. (2017). The neurobiology of depression: An integrated view. Asian Journal of Psychiatry, 27, 101–111. https://doi.org/10.1016/j.ajp.2017.01.025

Agus, A., Planchais, J., & Sokol, H. (2018). Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host & Microbe, 23(6), 716–724. https://www.cell.com/cell-host-microbe/fulltext/S1931-3128(18)30257-9?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1931312818302579%3Fshowall%3Dtrue

Bonaz, B., Bazin, T., & Pellissier, S. (2018). The vagus nerve at the interface of the microbiota-gut-brain axis. Frontiers in Neuroscience, 12, Article 49. https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2018.00049/full

Bourassa, M. W., et al. (2016). Butyrate, neuroepigenetics and the gut microbiome: Can a high fiber diet improve brain health? Frontiers in Neuroscience, 10, Article 42. https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2016.00042/full

Bravo, J. A., et al. (2011). Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in mice via the vagus nerve. Proceedings of the National Academy of Sciences of the United States of America, 108(38), 16050–16055. https://www.pnas.org/doi/full/10.1073/pnas.1102999108

Chahwan, B., et al. (2019). Gut feelings: A randomised, triple-blind, placebo-controlled trial of probiotics for depressive symptoms. BMJ Open, 9, Article e026546. https://pubmed.ncbi.nlm.nih.gov/31078831/

Cryan, J. F., O’Riordan, K. J., Cowan, C. S. M., et al. (2019). The microbiota-gut-brain axis. Physiological Reviews, 99(4), 1877–2013. https://journals.physiology.org/doi/full/10.1152/physrev.00018.2018

Dalile, B., et al. (2019). The role of short-chain fatty acids in microbiota-gut-brain communication. Nature Reviews Gastroenterology & Hepatology, 16(8), 461–478. https://www.nature.com/articles/s41575-019-0157-3

Dean, J., & Keshavan, M. (2017). The neurobiology of depression: An integrated view. Asian Journal of Psychiatry, 27, 101–111. https://www.sciencedirect.com/science/article/abs/pii/S1876201816303197?via%3Dihub

Desbonnet, L., Garrett, L., Clarke, G., Bienenstock, J., & Dinan, T. G. (2010). The probiotic Bifidobacteria infantis: An assessment of potential antidepressant properties in the rat. Neuroscience, 170(4), 1179–1188. https://www.ibroneuroscience.org/article/S0306-4522(10)01072-9/abstract

Dinan, T. G., & Cryan, J. F. (2020). Gut microbiota: A missing link in psychiatry. World Psychiatry, 19(1), 111–112. https://onlinelibrary.wiley.com/doi/10.1002/wps.20727

Dinan, T. G., Stanton, C., & Cryan, J. F. (2013). Psychobiotics: A novel class of psychotropic. Biological Psychiatry, 74(10), 720–726. https://pubmed.ncbi.nlm.nih.gov/23759244/

Erny, D., et al. (2015). Host microbiota constantly control maturation and function of microglia in the CNS. Nature Neuroscience, 18(7), 965–977. https://pubmed.ncbi.nlm.nih.gov/26030851/

Fasano, A. (2021). Gut permeability, intestinal microbiota and mental health. Gut, 70(8), 1515–1517. https://www.usbiotek.com/blog/the-role-of-zonulin

Foster, J. A., & McVey Neufeld, K. A. (2019). Gut-brain axis: How the microbiome influences anxiety and depression. Trends in Neurosciences, 42(11), 799–810. https://www.cell.com/trends/neurosciences/abstract/S0166-2236(19)30135-3?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0166223619301353%3Fshowall%3Dtrue

Haghighat, N., et al. (2021). Synbiotic supplementation and depression severity: A randomized controlled trial. Clinical Nutrition, 40(3), 1598–1606. https://www.clinicalnutritionjournal.com/article/S0261-5614(20)30461-1/fulltext

Huang, R., et al. (2023). Probiotics for the treatment of anxiety and depression: A systematic review and meta-analysis. Psychiatry Research, 324, Article 115204. https://pubmed.ncbi.nlm.nih.gov/34620373/

Jacka, F. N., et al. (2017). A randomised controlled trial of dietary improvement for adults with major depression (the SMILES trial). BMC Medicine, 15, Article 23. https://link.springer.com/article/10.1186/s12916-017-0791-y

Kazemi, A., et al. (2019). Effect of probiotic and prebiotic supplementation on psychological symptoms in patients with depression: A randomized clinical trial. Clinical Nutrition, 38(2), 522–528. https://pubmed.ncbi.nlm.nih.gov/29731182/

Kelly, J. R., et al. (2022). Breaking down the barriers: The gut microbiome, intestinal permeability and stress-related psychiatric disorders. Frontiers in Cellular https://pmc.ncbi.nlm.nih.gov/articles/PMC4604320/

Köhler, C. A., et al. (2017). Peripheral cytokine and chemokine alterations in depression: A meta-analysis of 82 studies. Molecular Psychiatry, 22(5), 706–716. https://www.nature.com/articles/mp2016167

Liu, R. T., Walsh, R. F. L., & Sheehan, A. E. (2019). Prebiotics and probiotics for depression and anxiety: A systematic review and meta-analysis of controlled clinical trials. Neuroscience & Biobehavioral Reviews, 102, 13–23. https://www.sciencedirect.com/science/article/abs/pii/S0149763419300533?via%3Dihub

Maes, M., Kubera, M., & Leunis, J. C. (2008). The gut-brain barrier in major depression: Intestinal mucosal dysfunction with an increased translocation of LPS from gram-negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinology Letters, 29(1), 117–124. https://europepmc.org/article/med/18283240

Malard, A. M., et al. (2025). Psychobiotics and mental health: Emerging evidence and future perspectives. Nutrition Reviews, 83(2), 155–171. https://academic.oup.com/nutritionreviews/article/82/9/1216/7284364

Marx, W., et al. (2021). The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: A meta-analysis. Molecular Psychiatry, 26(8), 4158–4178. https://pubmed.ncbi.nlm.nih.gov/33230205/

McEwen, B. S. (1999). Stress and hippocampal plasticity. Annual Review of Neuroscience, 22, 105–122. https://www.annualreviews.org/content/journals/10.1146/annurev.neuro.22.1.105

Messaoudi, M., et al. (2011). Assessment of psychotropic-like properties of a probiotic formulation in rats and human subjects. British Journal of Nutrition, 105(5), 755–764. https://pubmed.ncbi.nlm.nih.gov/20974015/

Miller, A. H., & Raison, C. L. (2016). The role of inflammation in depression: From evolutionary imperative to modern treatment target. Nature Reviews Immunology, 16(1), 22–34. https://www.nature.com/articles/nri.2015.5

Ng, Q. X., Peters, C., Ho, C. Y. X., Lim, D. Y., & Yeo, W. S. (2023). A meta-analysis of the use of probiotics to alleviate depressive symptoms. Nutrients, 15(3), Article 612. https://www.mdpi.com/2072-6643/15/3/612

Nikolova, V. L., Hall, M. R. B., Hall, L. J., Cleare, A. J., Stone, J. M., & Young, A. H. (2024). Perturbations in gut microbiota composition in psychiatric disorders: A review and meta-analysis. JAMA Psychiatry, 81(1), 55–65. https://pubmed.ncbi.nlm.nih.gov/34524405/

O’Mahony, S. M., Clarke, G., Borre, Y. E., Dinan, T. G., & Cryan, J. F. (2015). Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behavioural Brain Research, 277, 32–48. https://www.sciencedirect.com/science/article/abs/pii/S0166432814004768?via%3Dihub

Pariante, C. M., & Lightman, S. L. (2008). The HPA axis in major depression: Classical theories and new developments. Trends in Neurosciences, 31(9), 464–468. https://www.cell.com/trends/neurosciences/abstract/S0166-2236(08)00164-1?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0166223608001641%3Fshowall%3Dtrue

Rush, A. J., et al. (2006). Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps. American Journal of Psychiatry, 163(11), 1905–1917. https://psychiatryonline.org/doi/10.1176/ajp.2006.163.11.1905

Rudzki, L., et al. (2019). Lactobacillus plantarum 299v supplementation improves cognitive performance and decreases kynurenine concentration in patients with major depression. Psychoneuroendocrinology, 100, 213–222. https://www.sciencedirect.com/science/article/abs/pii/S0306453018302695?via%3Dihub

Sarkar, A., et al. (2016). Psychobiotics and the manipulation of bacteria-gut-brain signals. Trends in Neurosciences, 39(11), 763–781. https://www.cell.com/trends/neurosciences/fulltext/S0166-2236(16)30113-8?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0166223616301138%3Fshowall%3Dtrue

Savitz, J. (2017). Role of kynurenine metabolism pathway activation in major depressive disorders. International Journal of Tryptophan Research, 10, Article 1178646917691938. https://journals.sagepub.com/doi/10.1177/1178646917691938

Schneider, E., et al. (2023). Probiotic supplementation improves cognitive function in major depressive disorder. Translational Psychiatry, 13, Article 198. https://www.nature.com/articles/s41398-025-03274-x

Schwarcz, R., Bruno, J. P., Muchowski, P. J., & Wu, H. Q. (2012). Kynurenines in the mammalian brain: When physiology meets pathology. Nature Reviews Neuroscience, 13(7), 465–477. https://www.nature.com/articles/nrn3257

Sender, R., Fuchs, S., & Milo, R. (2016). Revised estimates for the number of human and bacteria cells in the body. PLOS Biology, 14(8), Article e1002533. https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1002533

Skonieczna-Żydecka, K., et al. (2024). Synbiotics in psychiatric disorders: Mechanisms and therapeutic implications. Nutrients, 16(2), Article 281. https://www.mdpi.com/2072-6643/16/2/281

Stilling, R. M., et al. (2014). Friends with social benefits: Host-microbe interactions as a driver of brain evolution and development? Frontiers in Cellular and Infection Microbiology, 4, Article 147. https://www.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2014.00147/full

Strandwitz, P. (2018). Neurotransmitter modulation by the gut microbiota. Brain Research, 1693, 128–133. https://www.sciencedirect.com/science/article/abs/pii/S0006899318301501?via%3Dihub

Sudo, N., et al. (2004). Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. The Journal of Physiology, 558(Pt. 1), 263–275. https://physoc.onlinelibrary.wiley.com/doi/10.1113/jphysiol.2004.063388

Tian, P., et al. (2022). Bifidobacterium breve CCFM1025 attenuates major depression disorder via regulating gut microbiome and tryptophan metabolism: A randomized clinical trial. EBioMedicine, 80, Article 104039. https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(22)00220-1/fulltext

Tsigos, C., & Chrousos, G. P. (2002). Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. Journal of Psychosomatic Research, 53(4), 865–871. https://www.sciencedirect.com/science/article/abs/pii/S0022399902004294?via%3Dihub

Valles-Colomer, M., et al. (2019). The neuroactive potential of the human gut microbiota in quality of life and depression. Nature Microbiology, 4(4), 623–632. https://www.nature.com/articles/s41564-018-0337-x

Wang, Y., & Kasper, L. H. (2021). The role of microbiome in central nervous system disorders. Brain, Behavior, and Immunity, 38, 1–12. https://www.sciencedirect.com/science/article/abs/pii/S0889159121000192?via%3Dihub

Wallace, C. J. K., & Milev, R. (2017). The effects of probiotics on depressive symptoms in humans: A systematic review. Annals of General Psychiatry, 16, Article 14. https://link.springer.com/article/10.1186/s12991-017-0138-2

Wallace, C. J. K., & Milev, R. (2021). Probiotics in the treatment of mood disorders. Nutritional Neuroscience, 24(9), 674–693. https://pubmed.ncbi.nlm.nih.gov/33658952/

World Health Organization. (2025, August 29). Depressive disorder (depression). https://www.who.int/news-room/fact-sheets/detail/depression

Ferrari, A. J., et al. (2013). Burden of depressive disorders by country, sex, age, and year: Findings from the Global Burden of Disease Study 2010. PLOS Medicine, 10(11), Article e1001547. https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1001547

Srikantha, P., & Mohajeri, M. H. (2019). The possible role of the microbiota-gut-brain-axis in autism spectrum disorder. International Journal of Molecular Sciences, 20(9), Article 2115. https://www.mdpi.com/1422-0067/20/9/2115

Downloads

Published

2026-11-09

How to Cite

Biletska, A., Abramchuk, O. ., Fomenko, Y. ., Shchebetun, A. ., Koshlak, L. ., Chiernobaievska, O. ., Miliuk, K. ., Plakhotniuk, A. ., Postolaki, M. ., Zhaharina, I. ., Manila, Y. ., & Dubova, Y. . (2026). THE GUT–BRAIN AXIS AND PSYCHOBIOTICS: IMPLICATIONS FOR MENTAL HEALTH – A NARRATIVE REVIEW. International Journal of Innovative Technologies in Social Science, 1(4(52). https://doi.org/10.31435/ijitss.4(52).2026.6802

Most read articles by the same author(s)

1 2 > >>